Investigation of the Psychosocial Factors Responsible for the Late Recourse to HIV Testing Within MSM

AIDS Clinical Trial

— ReTarD  

Official title:

The Issue of Late Recourse to HIV Testing. A Study of the Psychosocial Factors at Play Within Men Who Have Sex With Men in France.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03661203
• Other study ID #: ANRS ReTarD VIH
• Secondary ID: 2018-A00825-50
• Status: Not yet recruiting
• Start date: September 2020
• Est. completion date: March 2022

Study information

• Verified date: January 2020
• Source: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
• Contact: Marie Préau, PR
• Phone: +33 4 78 77 31 63
• Email: marie.preau[@]univ-lyon2.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The present study will try to investigate and analyze the psycho-social hindrances and levers concerning the recourse to late HIV testing among the MSM population.

This study is divided in two parts. The first one will consist of individual and groups interviews. Then, depending on the items that will rise from the first part of the study, groups interview will take place based on theses items. Finally, a questionnaire build from the collected information will be sent to MSM community in order to obtain quantitative results.

Description:

The late recourse to HIV testing, among the population in general way and among MSM population in a more specific way, participates in the dissemination of the HIV epidemic. Actually, there is no cure for HIV infection, but treatments that reduce viral charge to undetectable level exists. When diagnosed and treated earlier, seropositive people will be less communicating the virus because of the reduction of their viral charge.

This study aims to uncover the reasons behind the late recourse to HIV testing in MSM population facing a high risk of contamination.

The study hypothesis, is that late recourse to HIV testing is probably related to social and economics factors like age, social standing, accessibility to the diagnosis or even to a traditional beliefs or a fear of stigma etc. To shed the light on these factors, the main objectives of the investigator will try to investigate and analyze the psycho-social hindrances and levers through a quantitative and qualitative approach. This plurality of approaches is a part of a methodological triangulation method described by Kalampalikis & Apostolidis, 2016.

People among MSM community having had a late or very late HIV test (as defined by biological parameters :CD4≤200/mm3 or having been diagnosed with AIDS), will be recruited in this study. During the first phase of the study, the eligible population will participate to individual or group interview . This qualitative part of the project will allow the set up of a questionnaire that will be diffused widely to the MSM community to have quantitative results.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1190
• Est. completion date: March 2022
• Est. primary completion date: March 2021
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• HIV-positive

• Self-reported homo-or bisexual contamination mode

• TCD4 + / mm3 200 200 lymphocyte count or Have an AIDS classifying event

• Diagnosis of HIV positive for at least two months and for a maximum of 24 months

Exclusion Criteria:

• Primary infection

Related Conditions & MeSH terms

• AIDS
• HIV Seropositivity

Intervention

Behavioral:
• Focus group
Focus group for qualitative group only
• Individual interview
Individual interview for qualitative group only
• online self questionnaire
online self questionnaire
• self questionnaire
online self questionnaire following focus group or individual interview For qualitative group only

Locations

Country	Name	City	State
France	Hôpital Bichat Claude-Bernard	Paris
France	Hôpital Pitié-Salpêtrière	Paris
France	Hopital Saint-Antoine	Paris
France	Le 190	Paris

Sponsors (2)

Lead Sponsor	Collaborator
French National Agency for Research on AIDS and Viral Hepatitis	University of Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Socio-representational elements associated with the very late use of the HIV test	Imbrication of representations and tests related to HIV	3 years
Secondary	Means of risk management	Use of screening in the management of the risk of seroconversion	3 years
Secondary	Representation and Knowledge of prevention methods	To understand the links between the different uses or non-uses of the biomedical prevention methods TasP (Treatment as Prevention), PrEP (Pre-Exposure Prohylaxis) and the methods of recourse to the screening test.	3 years
Secondary	Sense of community belonging	Understand the interaction links between community belonging and the use of the screening test.	3 years